(IN BRIEF) AstraZeneca’s Supplemental Biologics License Application (sBLA) seeking approval for a self- or caregiver-administered option for FluMist Quadrivalent, a needle-free nasal spray flu vaccine, has been accepted for review by the US Food and Drug Administration (FDA). If approved, … Read the full press release
(IN BRIEF) Evonik’s life sciences division, Nutrition & Care, has introduced GMP (Good Manufacturing Practices) production of PhytoSquene®, a non-animal-derived squalene derived from amaranth oil. PhytoSquene® offers a sustainable alternative to squalene sourced from shark liver oil and is intended … Read the full press release
Posted in Business, Chemicals, Germany, Healthcare, Industrial, Management, News, Pharma & Biotech, Science
Tagged Evonik, GMP Production, Paul Spencer, Pharmaceutical Use, PhytoSquene®, Plant-Based Squalene
(IN BRIEF) AstraZeneca and Daiichi Sankyo have received European Union (EU) approval for their drug Enhertu as a monotherapy for the treatment of advanced non-small cell lung cancer (NSCLC) in adult patients with activating HER2 mutations who require systemic therapy … Read the full press release
Posted in Business, Environment, European Union, Healthcare, Industrial, Management, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged AstraZeneca, Daiichi Sankyo, Dave Fredrickson, Enhertu, EU approval, HER2-Mutant, Ken Keller, lung cancer, Martin Reck, monotherapy, NSCLC, partnership, sustainability
(IN BRIEF) Philips has completed a comprehensive analysis of Tampere Heart Hospital’s environmental sustainability, focusing on interventional cardiology and carbon footprint evaluation. The findings have been transformed into a joint action plan to expedite the hospital’s efforts to achieve net-zero … Read the full press release
Posted in Business, Environment, Financial, Finland, Healthcare, Industrial, Investment, Management, Netherlands, News, Science, Technology
Tagged Aki Haukilahti, environmental, Finland, partnership, Pasi Lehto, Philips, Robert Metzke, sustainability, Tampere Heart Hospital
(IN BRIEF) Philips is set to showcase its latest innovations in cardiology at the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting in San Francisco, USA. The company will present a comprehensive portfolio of image-guided therapy and echocardiography solutions designed to support … Read the full press release
Posted in Business, Healthcare, Industrial, Management, Media, Netherlands, News, Science, Technology
Tagged Bert van Meurs, cardiology, clinical data, Matthias Götberg, Philips, TCT 2023
(IN BRIEF) Philips has once again secured a place on Forbes’ 2023 “World’s Best Employers” list, ranking among the top 100 organizations globally. The company earned the title of the best employer in the Health Care Equipment & Services category. … Read the full press release
Posted in Awards, Business, Healthcare, Industrial, Management, Netherlands, News, Science, Technology
Tagged Awards, Forbes 2023, Health Care Equipment & Services, Heidi Sichien, Philips, World's Best Employers
(IN BRIEF) ViiV Healthcare, a global specialist HIV company, will present 23 abstracts at the 19th Annual European AIDS Conference (EACS 2023). These abstracts will cover various aspects of HIV treatment and prevention, including real-world data on long-acting and 2-drug … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, Media, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Apretude, Dovato, EACS 2023, GSK, HIV, Kimberly Smith, partnership, Pfizer, prevention, Rekambys, Rukobia, Shionogi, treatment, ViiV Healthcare, Vocabria
(IN BRIEF) Soliris (eculizumab) has received approval in China for the treatment of adult patients with neuromyelitis optica spectrum disorder (NMOSD) who are anti-aquaporin-4 (AQP4) antibody positive (Ab+). This makes Soliris the first and only complement inhibitor approved for NMOSD … Read the full press release
(IN BRIEF) Merck, a leading science and technology company, has announced its expectation to return to organic sales growth in fiscal 2024. This was revealed during the company’s Capital Markets Day. Despite challenging market conditions in its Life Science and … Read the full press release
Posted in Artificial Intelligence (AI), Business, Electronics & Machinery, Financial, Germany, Healthcare, Management, Pharma & Biotech, Technology
Tagged artificial-intelligence, BAVENCIO™, Belén Garijo, Capital Markets Day, electronics, evobrutini, Healthcare, Internet of Things, IoT, Life Science, MAVENCLAD, Merck, semiconductor materials, Xevinapant
(IN BRIEF) Servier, a global pharmaceutical group, has partnered with Owkin, a biotech company specializing in AI-driven drug discovery and diagnostics, to accelerate the development of better-targeted therapies in various disease areas, including oncology. The collaboration aims to leverage AI … Read the full press release
Posted in Artificial Intelligence (AI), Business, Education, Environment, Financial, France, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged AI, Claude Bertrand, Disease Treatment, INNOVATION, oncology, Owkin, partnership, Servier, sustainability, therapies, Thomas Clozel
(IN BRIEF) Merck, a leading science and technology company, is set to present 28 abstracts at the 2023 European Society of Medical Oncology (ESMO) Annual Meeting in Madrid. These abstracts will showcase the latest research on Merck’s oncology portfolio, addressing … Read the full press release
Posted in Business, Germany, Healthcare, Management, Media, News, Pharma & Biotech, Science, Spain, Technology
Tagged BAVENCIO™, bladder, cancer treatment, colorectal, ERBITUX, ESMO 2023, head and neck, lung, Madrid, Merck, oncology, TEPMETKO, Xevinapant
(IN BRIEF) Philips is introducing AI-enabled point-of-care OB/GYN ultrasound solutions and intelligent workflows at the International Society in Obstetrics and Gynecology (ISUOG) 2023 World Congress. These innovations aim to aid in the early detection of abnormalities in pregnancy and gynecological … Read the full press release
Posted in Business, Healthcare, Industrial, Management, Netherlands, News, Science, Technology
Tagged AI, Dr. Michael Ruma, Early Detection, Matthijs Groot Wassink, Obstetrics and Gynecology, Philips, ultrasound
(IN BRIEF) Healthcare workers in the Twente and eastern Achterhoek regions of the Netherlands participated in an escape room simulation of a cyber attack organized by Acute Zorg Euregio (AZE), a regional network of organizations involved in acute care. The … Read the full press release
Posted in Business, Education, Healthcare, Industrial, Management, Netherlands, News, Science, Security & Safety, Technology
Tagged Acute Zorg Euregio (AZE), awareness, Cybersecurity, Cybertruck', Escape Room, healthcare workers, Jan-Willem Bullee, Luka Koning, Netherlands, Robin Schär, University of Twente
(IN BRIEF) BioNTech will be presenting updates on multiple programs across its oncology pipeline at the European Society for Molecular Oncology (ESMO) Congress 2023. These updates include data on investigational CAR-T and ex-vivo T cell therapies, a novel ADC (antibody-drug … Read the full press release
Posted in Business, Education, Germany, Healthcare, Industrial, Management, Media, News, Pharma & Biotech, Science, Technology
Tagged BioNTech, BNT211, BNT325, cancer therapy, CAR-T, ESMO Congress 2023, ex-vivo T cell therapies, Prof. Özlem Türeci
(IN BRIEF) AstraZeneca’s supplemental New Drug Application (sNDA) for Tagrisso (osimertinib) in combination with chemotherapy has been granted Priority Review by the US Food and Drug Administration (FDA) for the treatment of adult patients with locally advanced or metastatic epidermal … Read the full press release
Posted in Business, Education, Healthcare, Industrial, Management, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged AstraZeneca, chemotherapy, EGFR, FLAURA2, lung cancer, osimertinib, Susan Galbraith, Tagrisso, Treatment USA
(IN BRIEF) GSK has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for the approval of Jemperli (dostarlimab) in combination with chemotherapy as a frontline treatment for adult … Read the full press release
Posted in Business, Education, Healthcare, Industrial, Management, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged chemotherapy, CHMP, dostarlimab, endometrial cancer, GSK, Hesham Abdullah, Jemperli, RUBY, treatment
(IN BRIEF) The European Investment Bank (EIB) reaffirms its commitment to supporting sustainable development in the Western Balkans. During the Berlin Process Leaders’ Summit in Tirana, EIB Vice-President Czerwińska emphasized the bank’s dedication to enhancing connectivity, promoting green and digital … Read the full press release
Posted in Albania, Banks, Business, Education, Energy, Gas & Oil, European Union, Financial, Healthcare, Investment, Luxembourg
Tagged Berlin Process Leaders’ Summit, connectivity, digital transition, EIB, EIB Global, energy transition, Just Transition, Teresa Czerwińska, Tirana, WBIF, Western Balkans, Western Balkans Investment Framework
(IN BRIEF) Dr. Anne-Beatrice Kihara has officially assumed the role of President of the International Federation of Gynecology and Obstetrics (FIGO), marking a historic moment as she becomes the organization’s first-ever President from sub-Saharan Africa. The inauguration took place at … Read the full press release
Posted in Business, Healthcare, Industrial, Management, News, Science, United Kingdom
Tagged appointment, Dr. Anne-Beatrice Kihara, FIGO, First Sub-Saharan African, leadership, President, Women’s Health
(IN BRIEF) EpimAb Biotherapeutics, a clinical-stage biopharmaceutical company specializing in multispecific antibodies, and Almirall, a global biopharmaceutical company focused on medical dermatology, have entered into a license agreement to develop bispecific antibodies for up to three undisclosed target pairs. Almirall … Read the full press release
Posted in Business, Environment, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Spain, Technology
Tagged Almirall, antibodies, Dr. Chengbin Wu, EpimAb, Fabs-In-Tandem Immunoglobulin (FIT-Ig®), Karl Ziegelbauer, Multiple Targets, partnership, sustainability
(IN BRIEF) QIAGEN is organizing the Global TB Clinical and Educational Summit 2023, running from October 17-19, with the theme “Tackling TB together: From awareness to action.” This summit highlights QIAGEN’s dedication to combat tuberculosis (TB) and address the gap … Read the full press release
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?